federal_register: 2014-09771

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2014-09771 Allergy Laboratories, Inc., Opportunity for Hearing on Proposal To Revoke U.S.; License No. 103 Notice The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the biologics license (U.S. License No. 103) issued to Allergy Laboratories, Inc. for the manufacture of nonstandardized allergenic extract Dust, House Mixture. The proposed revocation is based on available scientific and medical information that does not support the safety and effectiveness of this nonstandardized allergenic extract. 2014-04-30 2014 4 https://www.federalregister.gov/documents/2014/04/30/2014-09771/allergy-laboratories-inc-opportunity-for-hearing-on-proposal-to-revoke-us-license-no-103 https://www.govinfo.gov/content/pkg/FR-2014-04-30/pdf/2014-09771.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the biologics license (U.S. License No. 103) issued to Allergy Laboratories, Inc. for the manufacture of nonstandardized allergenic extract Dust,...  

Links from other tables